The Gambia

in page functions
Total population (2012)1,824,777
Birth cohort (2012)67,885
Surviving Infants (surviving to 1 year per year, 2012)63,324
Infant mortality rate (deaths < 1 year per 1000 births, 2011)57.60/1000
Child mortality rate (deaths < 5 years per 1000 births, 2011)100.60/1000
World Bank Index, IDA (2012)3.35
Gross Nation Income (per capita US$, 2011)500
Co-financing status (2012)Low-income
No. of districts/territories (2011)6

GAVI support for Gambia

Type of support

Approvals

2001-2016 (US$)
(30 Apr 2013)

Commitments

2001-2016 (US$)
(30 Apr 2013)

Disbursements

2001-2012 (US$)
(30 Apr 2013)

% Disbursed

(30 Apr 2013)
200220032004200520062007200820092010201120122013201420152016
Health System Strengthening (HSS)$364,000$738,500
HepB mono (NVS)$455,977$455,977$455,977100%
Hib mono (NVS)$410,021$410,021$410,021100%
Immunisation Services Support (ISS)$602,800$602,800$545,30090%
Injection Safety Support (INS)$101,184$101,184$101,184100%
Measles (NVS)$50,769$142,269$51,790102%
Meningitis A - campaign (NVS)$792,500$792,500$797,021101%
Meningitis A - operational costs (OPC)$727,500$727,500
Penta (NVS)$2,969,846$4,202,846$2,942,29899%
Pneumo (NVS)$4,036,892$6,273,392$3,712,52292%
Rotavirus (NVS)$1,789,500$3,526,500
Tetra DTP-Hib (NVS)$3,675,683$3,675,683$3,675,683100%
Vaccine Introduction Grant$906,250$906,250$806,25089%
Total$16,882,922$22,555,422$13,498,046

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Gambia DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2011)

Grade of Confidence
96%

*
DTP3 - Official country estimates (2011)96%
M:F sex ratio at birth (2012)1.03
Household survey: DTP3 coverage for male (2005)84.70%
Household survey: DTP3 coverage for female (2005)89.00%
Household survey: Last DTP3 survey (2010)95%
% districts achieving > 80% DTP3 coverage (2011)100%
% districts achieving < 50% DTP3 coverage (2011)0%
MCV WHO/UNICEF estimates (2011)91%
Polio WHO/UNICEF estimates (2011)95%

Breakdown of support

Non-vaccine supportVaccine support
11% 89%
$1,452,734 $12,045,312

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Gambia

14 May 2013

Default library results

Rotavirus leading cause of diarrhoea

The largest and most comprehensive study of childhood diarrhoea has confirmed rotavirus as the single biggest cause of diarrhoea-related death and illness in developing countries. This latest evidence suggests that a large number of children are dying from this vaccine-preventable pathogen, and supports the decision by the GAVI Alliance to prioritise rotavirus vaccines.

03 December 2012

MenAfriVac

100 millionth person receives lifesaving meningitis vaccine

A revolutionary meningitis vaccine will reach the 100 millionth person this week in a region of Africa that has been plagued by deadly epidemics for more than a century. The milestone will take place in northern Nigeria, part of Africa’s “meningitis belt’, where the country is conducting its second seasonal immunisation campaign against the disease.

09 November 2012

Mosquito

GAVI statement on latest interim trial data on malaria vaccine candidate

GAVI statement in response to the latest interim data on the trial of malaria vaccine candidate RTS,S published by Glaxosmithkline and Path malaria vaccine initiative.

close icon

modal window here